TreeWAS – Variant ID: rs7939886

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
I10 Essential (primary) hypertension	0.000	0.928	0.072
I10-I15 Hypertensive diseases	0.000	0.968	0.032
I11 Hypertensive heart disease	0.000	0.973	0.026
I13 Hypertensive heart and renal disease	0.000	0.977	0.023
I11.9 Hypertensive heart disease without (congestive) heart failure	0.000	0.978	0.021
I12 Hypertensive renal disease	0.000	0.979	0.021
I11.0 Hypertensive heart disease with (congestive) heart failure	0.000	0.979	0.021
I15 Secondary hypertension	0.000	0.980	0.020
R25.8 Other and unspecified abnormal involuntary movements	0.000	0.983	0.017
I13.9 Hypertensive heart and renal disease, unspecified	0.000	0.983	0.016
I13.2 Hypertensive heart and renal disease with both (congestive) heart failure and renal failure	0.000	0.983	0.016
I13.1 Hypertensive heart and renal disease with renal failure	0.000	0.983	0.016
I13.0 Hypertensive heart and renal disease with (congestive) heart failure	0.000	0.983	0.016
R25.1 Tremor, unspecified	0.000	0.983	0.017
R25 Abnormal involuntary movements	0.000	0.984	0.016
I12.0 Hypertensive renal disease with renal failure	0.000	0.985	0.015
I12.9 Hypertensive renal disease without renal failure	0.000	0.985	0.015
I15.8 Other secondary hypertension	0.000	0.985	0.014
I15.2 Hypertension secondary to endocrine disorders	0.000	0.985	0.014
I15.0 Renovascular hypertension	0.000	0.985	0.014
L57.0 Actinic keratosis	0.000	0.986	0.014
I15.9 Seconday hypertension, unspecified	0.000	0.987	0.013
I15.1 Hypertension secondary to other renal disorders	0.000	0.987	0.013
R25.2 Cramp and spasm	0.000	0.987	0.013
R25.3 Fasciculation	0.000	0.988	0.012
R25.0 Abnormal head movements	0.000	0.988	0.012
N83.0 Follicular cyst of ovary	0.010	0.990	0.000
K63.8 Other specified diseases of intestine	0.000	0.992	0.008
L57 Skin changes due to chronic exposure to nonionising radiation	0.000	0.992	0.008
K63.2 Fistula of intestine	0.000	0.993	0.007
K63 Other diseases of intestine	0.000	0.993	0.007
K63.0 Abscess of intestine	0.000	0.993	0.007
K63.1 Perforation of intestine (nontraumatic)	0.000	0.993	0.007
L57.8 Other skin changes due to chronic exposure to nonionising radiation	0.000	0.993	0.007
L57.4 Cutis laxa senilis	0.000	0.994	0.006
N83 Noninflammatory disorders of ovary, Fallopian tube and broad ligament	0.006	0.994	0.000
K63.4 Enteroptosis	0.000	0.994	0.006
L57.5 Actinic granuloma	0.000	0.994	0.006
L57.3 Poikiloderma of Civatte	0.000	0.994	0.006
L57.2 Cutis rhomboidalis nuchae	0.000	0.994	0.006
L57.1 Actinic reticuloid	0.000	0.994	0.006
N83.1 Corpus luteum cyst	0.006	0.994	0.000
N83.8 Other noninflammatory disorders of ovary, Fallopian tube and broad ligament	0.005	0.995	0.000
N83.5 Torsion of ovary, ovarian pedicle and Fallopian tube	0.005	0.995	0.000
N83.6 Haematosalpinx	0.005	0.995	0.000
N83.9 Noninflammatory disorder of ovary, Fallopian tube and broad ligament, unspecified	0.005	0.995	0.000
N90.7 Vulvar cyst	0.000	0.995	0.005
L57.9 Skin changes due to chronic exposure to nonionising radiation, unspecified	0.000	0.995	0.005
N83.3 Acquired atrophy of ovary and Fallopian tube	0.005	0.995	0.000
N83.7 Haematoma of broad ligament	0.005	0.995	0.000
N83.4 Prolapse and hernia of ovary and Fallopian tube	0.005	0.995	0.000
E21.0 Primary hyperparathyroidism	0.000	0.996	0.004
L40.9 Psoriasis, unspecified	0.000	0.996	0.004
C91.1 Chronic lymphocytic leukaemia	0.004	0.996	0.000
T90.2 Sequelae of fracture of skull and facial bones	0.004	0.996	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.004	0.996	0.000
C91 Lymphoid leukaemia	0.004	0.996	0.000
K63.9 Disease of intestine, unspecified	0.000	0.996	0.004
C88 Malignant immunoproliferative diseases	0.004	0.996	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.004	0.996	0.000
C83.3 Large cell (diffuse)	0.004	0.996	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.004	0.996	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.004	0.996	0.000
C81 Hodgkin's disease	0.004	0.996	0.000
N60.0 Solitary cyst of breast	0.000	0.996	0.004
Z51.4 Preparatory care for treatment, not elsewhere classified	0.004	0.996	0.000
C85.1 B-cell lymphoma, unspecified	0.004	0.996	0.000
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue	0.000	0.996	0.004
L03.3 Cellulitis of trunk	0.000	0.996	0.004
C95 Leukaemia of unspecified cell type	0.003	0.996	0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.000	0.996	0.004
C90.2 Plasmacytoma, extramedullary	0.003	0.996	0.000
N60.2 Fibroadenosis of breast	0.000	0.996	0.003
N60.1 Diffuse cystic mastopathy	0.000	0.996	0.003
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.003	0.997	0.000
C91.5 Adult T-cell leukaemia	0.003	0.997	0.000
C86 Other specified types of T/NK-cell lymphoma	0.003	0.997	0.000
K63.3 Ulcer of intestine	0.000	0.997	0.003
N60.4 Mammary duct ectasia	0.000	0.997	0.003
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.003	0.997	0.000
N90.9 Noninflammatory disorder of vulva and perineum, unspecified	0.000	0.997	0.003
Z97.5 Presence of (intra-uterine) contraceptive device	0.003	0.997	0.000
N60 Benign mammary dysplasia	0.000	0.997	0.003
N90 Other noninflammatory disorders of vulva and perineum	0.000	0.997	0.003
T82.8 Other complications of cardiac and vascular prosthetic devices, implants and grafts	0.000	0.997	0.003
C91.0 Acute lymphoblastic leukaemia	0.003	0.997	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.003	0.997	0.000
C91.7 Other lymphoid leukaemia	0.003	0.997	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.003	0.997	0.000
C91.3 Prolymphocytic leukaemia	0.003	0.997	0.000
C91.2 Subacute lymphocytic leukaemia	0.003	0.997	0.000
C95.9 Leukaemia, unspecified	0.003	0.997	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.003	0.997	0.000
C94 Other leukaemias of specified cell type	0.003	0.997	0.000
C93 Monocytic leukaemia	0.003	0.997	0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.000	0.997	0.003
C88.9 Malignant immunoproliferative disease, unspecified	0.003	0.997	0.000
C88.7 Other malignant immunoproliferative diseases	0.003	0.997	0.000
C88.3 Immunoproliferative small intestinal disease	0.003	0.997	0.000
C88.2 Gamma heavy chain disease	0.003	0.997	0.000
C88.1 Alpha heavy chain disease	0.003	0.997	0.000
E23.0 Hypopituitarism	0.000	0.997	0.003
N47 Redundant prepuce, phimosis and paraphimosis	0.000	0.997	0.003
C81.1 Nodular sclerosis	0.003	0.997	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.003	0.997	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.003	0.997	0.000
C81.9 Hodgkin's disease, unspecified	0.003	0.997	0.000
C81.0 Lymphocytic predominance	0.003	0.997	0.000
C91.9 Lymphoid leukaemia, unspecified	0.003	0.997	0.000
E21.3 Hyperparathyroidism, unspecified	0.000	0.997	0.003
C83.6 Undifferentiated (diffuse)	0.003	0.997	0.000
C83.5 Lymphoblastic (diffuse)	0.003	0.997	0.000
C83.4 Immunoblastic (diffuse)	0.003	0.997	0.000
C83.2 Mixed small and large cell (diffuse)	0.003	0.997	0.000
C90.3 Solitary plasmacytoma	0.003	0.997	0.000
C90.1 Plasma cell leukaemia	0.003	0.997	0.000
S64.2 Injury of radial nerve at wrist and hand level	0.003	0.997	0.000
C83.0 Small cell (diffuse)	0.003	0.997	0.000
C90.0 Multiple myeloma	0.003	0.997	0.000
C81.7 Other Hodgkin's disease	0.003	0.997	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.003	0.997	0.000
C81.3 Lymphocytic depletion	0.003	0.997	0.000
C81.2 Mixed cellularity	0.003	0.997	0.000
D48.1 Connective and other soft tissue	0.000	0.997	0.003
C83.7 Burkitt's tumour	0.003	0.997	0.000
L59 Other disorders of skin and subcutaneous tissue related to radiation	0.000	0.997	0.003
L58 Radiodermatitis	0.000	0.997	0.003
L56 Other acute skin changes due to ultraviolet radiation	0.000	0.997	0.003
L55 Sunburn	0.000	0.997	0.003
C91.4 Hairy-cell leukaemia	0.003	0.997	0.000
C95.7 Other leukaemia of unspecified cell type	0.003	0.997	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.003	0.997	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.003	0.997	0.000
C95.0 Acute leukaemia of unspecified cell type	0.003	0.997	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.003	0.997	0.000
E21.5 Disorder of parathyroid gland, unspecified	0.000	0.997	0.003
E21.4 Other specified disorders of parathyroid gland	0.000	0.997	0.003
E21.2 Other hyperparathyroidism	0.000	0.997	0.003
E27.4 Other and unspecified adrenocortical insufficiency	0.000	0.997	0.003
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.003	0.997	0.000
C85.0 Lymphosarcoma	0.003	0.997	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.003	0.997	0.000
C86.4 Blastic NK-cell lymphoma	0.003	0.997	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.003	0.997	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.003	0.997	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.003	0.997	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.003	0.997	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.003	0.997	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.003	0.997	0.000
C92 Myeloid leukaemia	0.003	0.997	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.003	0.997	0.000
N90.5 Atrophy of vulva	0.000	0.997	0.003
N90.4 Leukoplakia of vulva	0.000	0.997	0.003
L40 Psoriasis	0.000	0.997	0.003
E14.9 Without complications	0.000	0.997	0.003
N90.2 Severe vulvar dysplasia, not elsewhere classified	0.000	0.997	0.002
N90.0 Mild vulvar dysplasia	0.000	0.997	0.002
E23 Hypofunction and other disorders of pituitary gland	0.000	0.997	0.003
C93.9 Monocytic leukaemia, unspecified	0.002	0.997	0.000
C93.7 Other monocytic leukaemia	0.002	0.997	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.002	0.997	0.000
C93.2 Subacute monocytic leukaemia	0.002	0.997	0.000
C93.1 Chronic monocytic leukaemia	0.002	0.997	0.000
C93.0 Acute monocytic leukaemia	0.002	0.997	0.000
C94.7 Other specified leukaemias	0.002	0.997	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.002	0.997	0.000
C94.5 Acute myelofibrosis	0.002	0.997	0.000
C94.4 Acute panmyelosis	0.002	0.997	0.000
C94.3 Mast cell leukaemia	0.002	0.997	0.000
C94.2 Acute megakaryoblastic leukaemia	0.002	0.997	0.000
C94.1 Chronic erythraemia	0.002	0.997	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.002	0.997	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.002	0.997	0.000
C96.8 Histiocytic sarcoma	0.002	0.997	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.002	0.997	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.002	0.997	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.002	0.997	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.002	0.997	0.000
C96.3 True histiocytic lymphoma	0.002	0.997	0.000
C96.2 Malignant mast cell tumour	0.002	0.997	0.000
C96.1 Malignant histiocytosis	0.002	0.997	0.000
C96.0 Letterer-Siwe disease	0.002	0.997	0.000
C83.1 Small cleaved cell (diffuse)	0.002	0.997	0.000
N90.6 Hypertrophy of vulva	0.000	0.997	0.002
N60.9 Benign mammary dysplasia, unspecified	0.000	0.997	0.002
M22.4 Chondromalacia patellae	0.002	0.998	0.000
N90.8 Other specified noninflammatory disorders of vulva and perineum	0.000	0.998	0.002
R22.0 Localised swelling, mass and lump, head	0.002	0.998	0.000
N90.3 Dysplasia of vulva, unspecified	0.000	0.998	0.002
E23.2 Diabetes insipidus	0.000	0.998	0.002
L40.0 Psoriasis vulgaris	0.000	0.998	0.002
N90.1 Moderate vulvar dysplasia	0.000	0.998	0.002
I80.0 Phlebitis and thrombophlebitis of superficial vessels of lower extremities	0.000	0.998	0.002
O36.8 Maternal care for other specified foetal problems	0.000	0.998	0.002
L55.9 Sunburn, unspecified	0.000	0.998	0.002
L55.8 Other sunburn	0.000	0.998	0.002
L55.2 Sunburn of third degree	0.000	0.998	0.002
L55.1 Sunburn of second degree	0.000	0.998	0.002
L55.0 Sunburn of first degree	0.000	0.998	0.002
L56.9 Acute skin change due to ultraviolet radiation, unspecified	0.000	0.998	0.002
L56.8 Other specified acute skin changes due to ultraviolet radiation	0.000	0.998	0.002
L56.4 Polymorphous light eruption	0.000	0.998	0.002
L56.3 Solar urticaria	0.000	0.998	0.002
L56.2 Photocontact dermatitis [berloque dermatitis]	0.000	0.998	0.002
L56.1 Drug photoallergic response	0.000	0.998	0.002
L56.0 Drug phototoxic response	0.000	0.998	0.002
L58.9 Radiodermatitis, unspecified	0.000	0.998	0.002
L58.1 Chronic radiodermatitis	0.000	0.998	0.002
L58.0 Acute radiodermatitis	0.000	0.998	0.002
L59.9 Disorder of skin and subcutaneous tissue related to radiation, unspecified	0.000	0.998	0.002
L59.8 Other specified disorders of skin and subcutaneous tissue related to radiation	0.000	0.998	0.002
L59.0 Erythema ab igne [dermatitis ab igne]	0.000	0.998	0.002
C84.9 Mature T/NK-cell lymphoma, unspecified	0.002	0.998	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.002	0.998	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.002	0.998	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.002	0.998	0.000
C84.3 Lymphoepithelioid lymphoma	0.002	0.998	0.000
C84.2 T-zone lymphoma	0.002	0.998	0.000
C84.1 Sezary's diease	0.002	0.998	0.000
C84.0 Mycosis fungoides	0.002	0.998	0.000
C92.1 Chronic myeloid leukaemia	0.002	0.998	0.000
I83.0 Varicose veins of lower extremities with ulcer	0.002	0.998	0.000
S80.1 Contusion of other and unspecified parts of lower leg	0.000	0.998	0.002
C84.5 Other and unspecified T-cell lymphomas	0.002	0.998	0.000
T90 Sequelae of injuries of head	0.002	0.998	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.002	0.998	0.000
S80.8 Other superficial injuries of lower leg	0.000	0.998	0.002
C82.3 Follicular lymphoma grade IIIa	0.002	0.998	0.000
C82.6 Cutaneous follicle centre lymphoma	0.002	0.998	0.000
C82.5 Diffuse follicle centre lymphoma	0.002	0.998	0.000
C82.4 Follicular lymphoma grade IIIb	0.002	0.998	0.000
C82.0 Small cleaved cell, follicular	0.002	0.998	0.000
C92.9 Myeloid leukaemia, unspecified	0.002	0.998	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.002	0.998	0.000
C92.7 Other myeloid leukaemia	0.002	0.998	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.002	0.998	0.000
C92.5 Acute myelomonocytic leukaemia	0.002	0.998	0.000
C92.4 Acute promyelocytic leukaemia	0.002	0.998	0.000
C92.3 Myeloid sarcoma	0.002	0.998	0.000
C92.2 Subacute myeloid leukaemia	0.002	0.998	0.000
L40.4 Guttate psoriasis	0.000	0.998	0.002
L40.3 Pustulosis palmaris et plantaris	0.000	0.998	0.002
L40.2 Acrodermatitis continua	0.000	0.998	0.002
L40.1 Generalised pustular psoriasis	0.000	0.998	0.002
C82.2 Large cell, follicular	0.002	0.998	0.000
S01.0 Open wound of scalp	0.002	0.998	0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified	0.000	0.998	0.002
E23.1 Drug-induced hypopituitarism	0.000	0.998	0.002
S92.30 Fracture of metatarsal bone (closed)	0.000	0.998	0.002
E23.6 Other disorders of pituitary gland	0.000	0.998	0.002
D52.9 Folate deficiency anaemia, unspecified	0.002	0.998	0.000
L40.8 Other psoriasis	0.000	0.998	0.002
M94.86 Other specified disorders of cartilage (Lower leg)	0.000	0.998	0.002
L40.5 Arthropathic psoriasis	0.000	0.998	0.002
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
E20-E35 Disorders of other endocrine glands	0.000	0.998	0.002
C85.7 Other specified types of non-Hodgkin's lymphoma	0.002	0.998	0.000
N81.3 Complete uterovaginal prolapse	0.000	0.998	0.002
M94.88 Other specified disorders of cartilage (Other)	0.000	0.998	0.002
C84.4 Peripheral T-cell lymphoma	0.002	0.998	0.000
O72.1 Other immediate postpartum haemorrhage	0.000	0.998	0.002
T90.1 Sequelae of open wound of head	0.002	0.998	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.002	0.998	0.000
T90.5 Sequelae of intracranial injury	0.002	0.998	0.000
Z97 Presence of other devices	0.002	0.998	0.000
I30.9 Acute pericarditis, unspecified	0.002	0.998	0.000
T90.9 Sequelae of unspecified injury of head	0.002	0.998	0.000
E27 Other disorders of adrenal gland	0.000	0.998	0.002
E23.7 Disorder of pituitary gland, unspecified	0.000	0.998	0.002
N60.3 Fibrosclerosis of breast	0.000	0.998	0.002
T90.8 Sequelae of other specified injuries of head	0.002	0.998	0.000
T90.3 Sequelae of injury of cranial nerves	0.002	0.998	0.000
T90.0 Sequelae of superficial injury of head	0.002	0.998	0.000
R22.2 Localised swelling, mass and lump, trunk	0.002	0.998	0.000
Z97.0 Presence of artificial eye	0.002	0.998	0.000
Z97.2 Presence of dental prosthetic device (complete)(partial)	0.002	0.998	0.000
E28 Ovarian dysfunction	0.000	0.998	0.002
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.002	0.998	0.000
M34.9 Systemic sclerosis, unspecified	0.002	0.998	0.000
E20 Hypoparathyroidism	0.000	0.998	0.002
M94.8 Other specified disorders of cartilage	0.000	0.998	0.002
M79.09 Rheumatism, unspecified (Site unspecified)	0.000	0.998	0.002
E35 Disorders of endocrine glands in diseases classified elsewhere	0.000	0.998	0.002
E32 Diseases of thymus	0.000	0.998	0.002
E31 Polyglandular dysfunction	0.000	0.998	0.002
E30 Disorders of puberty, not elsewhere classified	0.000	0.998	0.002
E25 Adrenogenital disorders	0.000	0.998	0.002
S80 Superficial injury of lower leg	0.000	0.998	0.002
Z97.8 Presence of other specified devices	0.002	0.998	0.000
K07.3 Anomalies of tooth position	0.000	0.998	0.002
Z97.1 Presence of artificial limb (complete)(partial)	0.002	0.998	0.000
M41.99 Scoliosis, unspecified (Site unspecified)	0.002	0.998	0.000
S01.2 Open wound of nose	0.002	0.998	0.000
T90.4 Sequelae of injury of eye and orbit	0.002	0.998	0.000
E27.5 Adrenomedullary hyperfunction	0.000	0.998	0.001
E27.3 Drug-induced adrenocortical insufficiency	0.000	0.998	0.001
E27.0 Other adrenocortical overactivity	0.000	0.998	0.001
E24 Cushing's syndrome	0.000	0.998	0.002
N60.8 Other benign mammary dysplasias	0.000	0.998	0.002
E28.3 Primary ovarian failure	0.000	0.998	0.001
E28.2 Polycystic ovarian syndrome	0.000	0.998	0.002
Z63.4 Disappearance and death of family member	0.000	0.998	0.002
R22.9 Localised swelling, mass and lump, unspecified	0.002	0.998	0.000
Z97.3 Presence of spectacles and contact lenses	0.001	0.998	0.000
E26 Hyperaldosteronism	0.000	0.998	0.001
M06.09 Seronegative rheumatoid arthritis (Site unspecified)	0.002	0.998	0.000
E20.9 Hypoparathyroidism, unspecified	0.000	0.998	0.001
E28.9 Ovarian dysfunction, unspecified	0.000	0.998	0.001
E28.8 Other ovarian dysfunction	0.000	0.998	0.001
E28.1 Androgen excess	0.000	0.998	0.001
E28.0 Oestrogen excess	0.000	0.998	0.001
Q21.0 Ventricular septal defect	0.002	0.998	0.000
R22 Localised swelling, mass and lump of skin and subcutaneous tissue	0.002	0.998	0.000
D23.0 Skin of lip	0.002	0.998	0.000
E20.8 Other hypoparathyroidism	0.000	0.998	0.001
E20.1 Pseudohypoparathyroidism	0.000	0.998	0.001
E20.0 Idiopathic hypoparathyroidism	0.000	0.998	0.001
M94.87 Other specified disorders of cartilage (Ankle and foot)	0.000	0.998	0.001
M94.85 Other specified disorders of cartilage (Pelvic region and thigh)	0.000	0.998	0.001
M94.84 Other specified disorders of cartilage (Hand)	0.000	0.998	0.001
M94.83 Other specified disorders of cartilage (Forearm)	0.000	0.998	0.001
M94.82 Other specified disorders of cartilage (Upper arm)	0.000	0.998	0.001
M94.81 Other specified disorders of cartilage (Shoulder region)	0.000	0.998	0.001
M94.80 Other specified disorders of cartilage (Multiple sites)	0.000	0.998	0.001
M24.16 Other articular cartilage disorders (Lower leg)	0.002	0.998	0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre	0.002	0.998	0.000
N41.0 Acute prostatitis	0.002	0.998	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
E25.9 Adrenogenital disorder, unspecified	0.000	0.998	0.001
E25.8 Other adrenogenital disorders	0.000	0.998	0.001
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency	0.000	0.998	0.001
E30.9 Disorder of puberty, unspecified	0.000	0.998	0.001
E30.8 Other disorders of puberty	0.000	0.998	0.001
E30.1 Precocious puberty	0.000	0.998	0.001
E30.0 Delayed puberty	0.000	0.998	0.001
E31.9 Polyglandular dysfunction, unspecified	0.000	0.998	0.001
E31.8 Other polyglandular dysfunction	0.000	0.998	0.001
E31.1 Polyglandular hyperfunction	0.000	0.998	0.001
E31.0 Autoimmune polyglandular failure	0.000	0.998	0.001
E32.9 Disease of thymus, unspecified	0.000	0.998	0.001
E32.8 Other diseases of thymus	0.000	0.998	0.001
E32.1 Abscess of thymus	0.000	0.998	0.001
E32.0 Persistent hyperplasia of thymus	0.000	0.998	0.001
E35.8 Disorders of other endocrine glands in diseases classified elsewhere	0.000	0.998	0.001
E35.1 Disorders of adrenal glands in diseases classified elsewhere	0.000	0.998	0.001
E35.0 Disorders of thyroid gland in diseases classified elsewhere	0.000	0.998	0.001
E29 Testicular dysfunction	0.000	0.998	0.001
F41.1 Generalised anxiety disorder	0.000	0.999	0.001
R22.3 Localised swelling, mass and lump, upper limb	0.001	0.999	0.000
S80.7 Multiple superficial injuries of lower leg	0.000	0.999	0.001
M94.26 Chondromalacia (Lower leg)	0.000	0.999	0.001
D80.1 Nonfamilial hypogammaglobulinaemia	0.001	0.999	0.000
E24.8 Other Cushing's syndrome	0.000	0.999	0.001
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.000	0.999	0.001
E24.3 Ectopic ACTH syndrome	0.000	0.999	0.001
E24.1 Nelson's syndrome	0.000	0.999	0.001
E24.0 Pituitary-dependent Cushing's disease	0.000	0.999	0.001
E27.8 Other specified disorders of adrenal gland	0.000	0.999	0.001
R79.9 Abnormal finding of blood chemistry, unspecified	0.001	0.999	0.000
R25-R29 Symptoms and signs involving the nervous and musculoskeletal systems	0.000	0.999	0.001
I20.1 Angina pectoris with documented spasm	0.001	0.999	0.000
K81.1 Chronic cholecystitis	0.001	0.999	0.000
G35 Multiple sclerosis	0.001	0.999	0.000
D51.9 Vitamin B12 deficiency anaemia, unspecified	0.001	0.999	0.000
E26.9 Hyperaldosteronism, unspecified	0.000	0.999	0.001
E26.8 Other hyperaldosteronism	0.000	0.999	0.001
E26.1 Secondary hyperaldosteronism	0.000	0.999	0.001
E27.1 Primary adrenocortical insufficiency	0.000	0.999	0.001
L92.3 Foreign body granuloma of skin and subcutaneous tissue	0.000	0.999	0.001
N92.1 Excessive and frequent menstruation with irregular cycle	0.001	0.999	0.000
S80.9 Superficial injury of lower leg, unspecified	0.000	0.999	0.001
E24.9 Cushing's syndrome, unspecified	0.000	0.999	0.001
S32.00 Fracture of lumbar vertebra (closed)	0.000	0.999	0.001
E24.2 Drug-induced Cushing's syndrome	0.000	0.999	0.001
E27.2 Addisonian crisis	0.000	0.999	0.001
R22.7 Localised swelling, mass and lump, multiple sites	0.001	0.999	0.000
S80.0 Contusion of knee	0.000	0.999	0.001
E34 Other endocrine disorders	0.000	0.999	0.001
E27.9 Disorder of adrenal gland, unspecified	0.000	0.999	0.001
K38.8 Other specified diseases of appendix	0.001	0.999	0.000
Q21.3 Tetralogy of Fallot	0.001	0.999	0.000
N18.9 Chronic renal failure, unspecified	0.000	0.999	0.001
Y42.5 Other oestrogens and progestogens	0.000	0.999	0.001
R81 Glycosuria	0.000	0.999	0.001
M94.89 Other specified disorders of cartilage (Site unspecified)	0.000	0.999	0.001
E29.9 Testicular dysfunction, unspecified	0.000	0.999	0.001
E29.8 Other testicular dysfunction	0.000	0.999	0.001
E29.0 Testicular hyperfunction	0.000	0.999	0.001
R22.1 Localised swelling, mass and lump, neck	0.001	0.999	0.000
C92.0 Acute myeloid leukaemia	0.001	0.999	0.000
Q27.3 Peripheral arteriovenous malformation	0.001	0.999	0.000
M94.2 Chondromalacia	0.000	0.999	0.001
Z97.4 Presence of external hearing-aid	0.001	0.999	0.000
E34.8 Other specified endocrine disorders	0.000	0.999	0.001
E26.0 Primary hyperaldosteronism	0.000	0.999	0.001
E34.5 Androgen resistance syndrome	0.000	0.999	0.001
E34.4 Constitutional tall stature	0.000	0.999	0.001
E34.3 Short stature, not elsewhere classified	0.000	0.999	0.001
E34.2 Ectopic hormone secretion, not elsewhere classified	0.000	0.999	0.001
E34.1 Other hypersecretion of intestinal hormones	0.000	0.999	0.001
K82.4 Cholesterolosis of gallbladder	0.001	0.999	0.000
N08.3 Glomerular disorders in diabetes mellitus	0.000	0.999	0.001
X49.9 Unspecified place	0.001	0.999	0.000
M94.29 Chondromalacia (Site unspecified)	0.000	0.999	0.001
M94.28 Chondromalacia (Other)	0.000	0.999	0.001
M94.27 Chondromalacia (Ankle and foot)	0.000	0.999	0.001
M94.25 Chondromalacia (Pelvic region and thigh)	0.000	0.999	0.001
M94.24 Chondromalacia (Hand)	0.000	0.999	0.001
M94.23 Chondromalacia (Forearm)	0.000	0.999	0.001
M94.22 Chondromalacia (Upper arm)	0.000	0.999	0.001
M94.21 Chondromalacia (Shoulder region)	0.000	0.999	0.001
M94.20 Chondromalacia (Multiple sites)	0.000	0.999	0.001
S32.70 Multiple fractures of lumbar spine and pelvis (closed)	0.000	0.999	0.001
E22 Hyperfunction of pituitary gland	0.000	0.999	0.001
L29.0 Pruritus ani	0.000	0.999	0.001
S92.3 Fracture of metatarsal bone	0.000	0.999	0.001
I38 Endocarditis, valve unspecified	0.001	0.999	0.000
S01 Open wound of head	0.001	0.999	0.000
M82.11 Osteoporosis in endocrine disorders (Shoulder region)	0.001	0.999	0.000
E04.9 Non-toxic goitre, unspecified	0.001	0.999	0.000
Q21 Congenital malformations of cardiac septa	0.001	0.999	0.000
E05.0 Thyrotoxicosis with diffuse goitre	0.001	0.999	0.000
I30.1 Infective pericarditis	0.001	0.999	0.000
S01.8 Open wound of other parts of head	0.001	0.999	0.000
S01.3 Open wound of ear	0.001	0.999	0.000
D52 Folate deficiency anaemia	0.001	0.999	0.000
M94 Other disorders of cartilage	0.000	0.999	0.001
M18.9 Arthrosis of first carpometacarpal joint, unspecified	0.001	0.999	0.000
S01.4 Open wound of cheek and temporomandibular area	0.001	0.999	0.000
M24.87 Other specific joint derangements, not elsewhere classified (Ankle and foot)	0.001	0.999	0.000
S92.31 Fracture of metatarsal bone (open)	0.000	0.999	0.001
E22.9 Hyperfunction of pituitary gland, unspecified	0.000	0.999	0.001
E22.8 Other hyperfunction of pituitary gland	0.000	0.999	0.001
E34.0 Carcinoid syndrome	0.000	0.999	0.001
N36.3 Prolapsed urethral mucosa	0.000	0.999	0.001
M25.66 Stiffness of joint, not elsewhere classified (Lower leg)	0.000	0.999	0.001
E22.1 Hyperprolactinaemia	0.000	0.999	0.001
M94.3 Chondrolysis	0.000	0.999	0.001
M94.1 Relapsing polychondritis	0.000	0.999	0.001
M94.0 Chondrocostal junction syndrome [Tietze]	0.000	0.999	0.001
Q21.9 Congenital malformation of cardiac septum, unspecified	0.001	0.999	0.000
Q21.8 Other congenital malformations of cardiac septa	0.001	0.999	0.000
Q21.4 Aortopulmonary septal defect	0.001	0.999	0.000
Q21.2 Atrioventricular septal defect	0.001	0.999	0.000
R49.0 Dysphonia	0.000	0.999	0.001
M21.67 Other acquired deformities of ankle and foot-Ankle/foot	0.000	0.999	0.001
D52.8 Other folate deficiency anaemias	0.001	0.999	0.000
D52.1 Drug-induced folate deficiency anaemia	0.001	0.999	0.000
D52.0 Dietary folate deficiency anaemia	0.001	0.999	0.000
E34.9 Endocrine disorder, unspecified	0.001	0.999	0.001
G90.0 Idiopathic peripheral autonomic neuropathy	0.001	0.999	0.000
Q27.8 Other specified congenital malformations of peripheral vascular system	0.001	0.999	0.000
E29.1 Testicular hypofunction	0.000	0.999	0.001
M94.09 Chondrocostal junction syndrome [Tietze]-Site unspec	0.000	0.999	0.001
M94.08 Chondrocostal junction syndrome [Tietze]-Other	0.000	0.999	0.001
M94.07 Chondrocostal junction syndrome [Tietze]-Ankle/foot	0.000	0.999	0.001
M94.06 Chondrocostal junction syndrome [Tietze]-Lower leg	0.000	0.999	0.001
M94.05 Chondrocostal junction syndrome [Tietze]-Pelvic/thigh	0.000	0.999	0.001
M94.04 Chondrocostal junction syndrome [Tietze]-Hand	0.000	0.999	0.001
M94.03 Chondrocostal junction syndrome [Tietze]-Forearm	0.000	0.999	0.001
M94.02 Chondrocostal junction syndrome [Tietze]-Upper arm	0.000	0.999	0.001
M94.01 Chondrocostal junction syndrome [Tietze]-Shldr region	0.000	0.999	0.001
M94.00 Chondrocostal junction syndrome [Tietze]-Mult sites	0.000	0.999	0.001
M94.19 Relapsing polychondritis (Site unspecified)	0.000	0.999	0.001
M94.18 Relapsing polychondritis (Other)	0.000	0.999	0.001
M94.17 Relapsing polychondritis (Ankle and foot)	0.000	0.999	0.001
M94.16 Relapsing polychondritis (Lower leg)	0.000	0.999	0.001
M94.15 Relapsing polychondritis (Pelvic region and thigh)	0.000	0.999	0.001
M94.14 Relapsing polychondritis (Hand)	0.000	0.999	0.001
M94.13 Relapsing polychondritis (Forearm)	0.000	0.999	0.001
M94.12 Relapsing polychondritis (Upper arm)	0.000	0.999	0.001
M94.11 Relapsing polychondritis (Shoulder region)	0.000	0.999	0.001
M94.10 Relapsing polychondritis (Multiple sites)	0.000	0.999	0.001
M94.39 Chondrolysis (Site unspecified)	0.000	0.999	0.001
M94.38 Chondrolysis (Other)	0.000	0.999	0.001
M94.37 Chondrolysis (Ankle and foot)	0.000	0.999	0.001
M94.36 Chondrolysis (Lower leg)	0.000	0.999	0.001
M94.35 Chondrolysis (Pelvic region and thigh)	0.000	0.999	0.001
M94.34 Chondrolysis (Hand)	0.000	0.999	0.001
M94.33 Chondrolysis (Forearm)	0.000	0.999	0.001
M94.32 Chondrolysis (Upper arm)	0.000	0.999	0.001
M94.31 Chondrolysis (Shoulder region)	0.000	0.999	0.001
M94.30 Chondrolysis (Multiple sites)	0.000	0.999	0.001
D25.2 Subserosal leiomyoma of uterus	0.001	0.999	0.000
Z87.8 Personal history of other specified conditions	0.000	0.999	0.001
Q27 Other congenital malformations of peripheral vascular system	0.001	0.999	0.000
M06.00 Seronegative rheumatoid arthritis (Multiple sites)	0.001	0.999	0.000
M11.26 Other chondrocalcinosis (Lower leg)	0.001	0.999	0.000
S01.7 Multiple open wounds of head	0.001	0.999	0.000
I30 Acute pericarditis	0.001	0.999	0.000
K56.1 Intussusception	0.001	0.999	0.000
M06.0 Seronegative rheumatoid arthritis	0.001	0.999	0.000
M94.9 Disorder of cartilage, unspecified	0.000	0.999	0.001
Q27.9 Congenital malformation of peripheral vascular system, unspecified	0.001	0.999	0.000
Q27.4 Congenital phlebectasia	0.001	0.999	0.000
Q27.2 Other congenital malformations of renal artery	0.001	0.999	0.000
Q27.1 Congenital renal artery stenosis	0.001	0.999	0.000
Q27.0 Congenital absence and hypoplasia of umbilical artery	0.001	0.999	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.001	0.999	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations